Effect of Vascular Inflow Occlusion in Open Liver Resection for Hepatocellular Carcinoma
Study Details
Study Description
Brief Summary
Bleeding is a major problem during liver resection. Vascular inflow occlusion, also known as Pringle maneuver, has been commonly employed to reduce blood loss during liver surgery. However, Pringle maneuver might cause ischaemic insult to the remnant liver and lead to post-operative liver dysfunction.
The investigators hypothesize that liver resection without the use of vascular inflow occlusion (Pringle maneuver) is associated with lower postoperative complications rate.
The aim of this study is to evaluate whether elective open liver resection without vascular inflow occlusion (Pringle Maneuvre) would lead to a reduction of post-operative surgical complications in patient with hepatocellular carcinoma.
Eligible patients undergoing liver resection in the Prince of Wales Hospital will be recruited and randomized into 2 study arms comparing the effect of Pringle maneuver.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Pringle Intermittent vascular inflow occlusion applied during liver resection |
Procedure: Pringle
Vascular clamp is applied across hepatoduodenal ligament intermittently in 15 minutes on / 5 minutes off interval
Other Names:
|
No Intervention: Non-Pringle No vascular inflow occlusion applied during liver resection |
Outcome Measures
Primary Outcome Measures
- Post-operative surgical complications [1 month]
30-day morbidity after open liver resection, which includes ascites, pleural effusion, wound infection and intra-abdominal collection
Secondary Outcome Measures
- Other post-operative complications [1 month]
post-operative liver failure, post-op mortality, operative blood loss, duration of operation and hospital stay
- Survival [5 year]
Overall and disease-free survival at 1, 3, 5-year
- Recurrence rate of hepatocellular carcinoma [5 year]
Recurrence rate of hepatocellular carcinoma at 1,3,5 year
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age >18
-
Child's A or B cirrhosis
Exclusion Criteria:
-
Informed consent not available
-
Presence of portal vein thrombosis, portal vein tumor thrombus, or previous portal vein embolisation
-
Presence of hepatic artery thrombosis, previous transarterial therapy like TACE, lipiodol-ethanol mixture injection or transarterial internal radiation
-
Anticipation of portal vein resection
-
Emergency hepatectomy
-
Ruptured HCC
-
Adhesion or anatomical variation that preclude safe and successful application of Pringle maneuver
-
Anticipation of concomitant bowel or bile duct resection
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | The Prince of Wales Hospital | Hong Kong | China |
Sponsors and Collaborators
- Chinese University of Hong Kong
Investigators
- Principal Investigator: Kit Fai Lee, MBBS, Clinical Associate Professor (honorary)
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CRE-2012.351-T